Yun MR, Kim DH, Kim SY, Joo HS, et al. Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naive and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer. Clin Cancer Res 2020 Apr 8. pii: 1078-0432.CCR-19-2777.
PMID: 32269053